personalized medicine
GenesisCare Takes Minority Stake in Precision Medicine Firm PreludeDx
Earlier this year, the companies signed a deal to expand access to PreludeDx's DCISionRT precision medicine breast cancer test in Australia and the US.
Bio-Me Raises NOK 10M for Microbiome Precision Medicine
The Oslo-based firm will use the funding to support clinical programs as well as to explore short-term revenue-generating opportunities.
A new publication detailing ctDNA testing results has spurred a minimal residual disease biomarker-directed trial for Roche's atezolizumab in bladder cancer.
Caris Life Sciences, Elevation Oncology Team on Targeted Drug Development
The companies are working together to mine Caris' multiomic data for new cancer drug targets, sharing drug/diagnostic development costs for chosen candidates.
The new reports link variants in CYP2C19 to the safety and efficacy of two drugs, a commonly prescribed antiplatelet drug and an antidepressant.
May 6, 2021
Guardant Health Q1 Revenues up 17 Percent
Mar 24, 2021
Scipher Medicine Raises $82M in Series C Financing
Feb 5, 2021
Nov 24, 2020